MAP1LC3B Knockout Cell Line - CD BioSciences

service-banner

MAP1LC3B Knockout Cell Line

MAP1LC3B Knockout Cell Line

SPL-01949

Size Price
1 Unit Online Inquiry
Description
4bp deletion
Target Information
Target Name LC3
Gene Abbr. MAP1LC3B
Gene ID 81631
Full Name microtubule associated protein 1 light chain 3 beta
Alias ATG8F, LC3B, MAP1A/1BLC3, MAP1LC3B-a
Species Human
Genomic Locus chr16:87402249
Transcript NM_022818
WT Expression Level 65.65 TPM (TPM = Transcripts per million; any value less than 3 is considered non-expressing)
Introduction The product of this gene is a subunit of neuronal microtubule-associated MAP1A and MAP1B proteins, which are involved in microtubule assembly and important for neurogenesis. Studies on the rat homolog implicate a role for this gene in autophagy, a process that involves the bulk degradation of cytoplasmic component. [provided by RefSeq, Jul 2008].
Product Details
Cell Line Model HAP1
Genotype HAP1 cell line, edited by CRISPR/Cas to contain a 4bp deletion in a coding exon of MAP1LC3B.
Description 4bp deletion
Parental Cell Line C631
Guide RNA Sequence TGAGCTCACTCATGTTGACA
PCR Primer Forward: AGATGGGGTTTCACCATGTTAGC
Reverse: ATGTTATGATGAAAGAAACGGGCTC
Handling Specifications
Revival Rapidly thaw cells in a 37°C water bath. Transfer contents into a tube containing pre-warmed media. Centrifuge cells and seed into 10 mL of pre-warmed media in a 10 cm dish.
Culture Medium IMDM + 10% FCS
Growth Properties Cells are adherent cells that are cultured at 37°C in a humidified atmosphere with 5% CO2. Cells should be passaged every 2-3 days, splitting approximately 1:10-1:20.
Freeze Medium IMDM + 20% FCS + 10% DMSO
Biosafety Level BSL-1
Disclaimer This product is classified under IATA regulations as a GMMO (genetically modified micro-organism) and will ship as UN3245. If applicable, ensure facility meets all requirements per local and country regulations.

For research use only. Not intended for any clinical use. No products from CD BioSciences may be resold, modified for resale or used to manufacture commercial products without prior written approval from CD BioSciences.